SuperworthBeam Therapeutics shares outstanding BEAM
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 104.3M
- On a year earlier
- +2.3%
- more shares
Beam Therapeutics had 104.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 102.9M | +24% |
| FY2024 | 82.8M | +2% |
| FY2023 | 80.9M | +14% |
| FY2022 | 70.8M | +4% |
| FY2021 | 68M | +20% |
| FY2020 | 56.5M | +691% |
| FY2019 | 7.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 104.3M | +2% | |
| Q1 FY26 | 103.3M | +17% | |
| Q4 FY25 | 102.9M | +24% | |
| Q3 FY25 | 102.6M | +24% | |
| Q2 FY25 | 102M | +24% | |
| Q1 FY25 | 88M | +8% | |
| Q4 FY24 | 82.8M | +2% | |
| Q3 FY24 | 82.4M | +4% | |
| Q2 FY24 | 82.3M | +8% | |
| Q1 FY24 | 81.7M | +13% | |
| Q4 FY23 | 80.9M | +14% | |
| Q3 FY23 | 79M | +12% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Beam Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.